TOP TIERMARKET NEWSWIRE

News & sentiment

BIOVENTUS INC A (BVS) — News & AI sentiment

BIOVENTUS INC A (BVS) news roundup. 14 stories in the past week, 15 over 30 days. Average 30-day sentiment is 47.2/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

14

avg sentiment 47/100

30d stories

15

avg sentiment 47.2/100

Insider net (90d)

$0

0 buys · 0 sells

Congress (90d)

0

0 buys · 0 sells

BVS news in the last 24 hours, 7 days, 30 days and 90 days

How much BVS coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	BVS stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	14	47/100	BVS headlines →
Last 30 days	15	47.2/100	BVS headlines →
Last 90 days	18	49.2/100	BVS headlines →

Latest stories on BVS

BVS Maintained by Canaccord Genuity -- Price Target Lowered to $18.00

GuruFocus38 · neutralanalyst

2d ago

Bioventus price target lowered to $16 from $18 at Craig-Hallum

The Fly34 · bearishanalyst

2d ago

Bioventus price target lowered to $16 from $18 at Barrington

The Fly34 · bearishanalyst

2d ago

Bioventus price target lowered to $18 from $19 at Canaccord

The Fly34 · bearishanalyst

2d ago

Bioventus (BVS) Reports 3% Revenue Growth in Q3 2026 Amid Strategic Review

GuruFocus54 · neutralearnings

2d ago

Bioventus Inc (BVS) Q3 2026 Earnings Call Highlights: Solid Pain and Ultrasonics Growth Offset by Bone Graft Softness

GuruFocus54 · neutralearnings

2d ago

Bioventus expects 2026 revenue of $590M-$595M while reaffirming adjusted EPS of $0.75-$0.79

Seeking Alpha58 · neutralearnings

2d ago

Bioventus Inc. (BVS) Q3 2026 Earnings Call Transcript

Seeking Alpha50 · neutralearnings

2d ago

Q3 2026 Bioventus Inc. Earnings Call Transcript

GuruFocus50 · neutralearnings

2d ago

Bioventus (BVS) Q3 2026 Earnings Call Transcript

The Motley Fool58 · neutralearnings

2d ago

Bioventus Shares Fall on 3Q Sales Miss, Cut to Outlook

MarketWatch34 · bearishearnings

3d ago

Bioventus Non-GAAP EPS of $0.17 beats by $0.01, revenue of $142.4M misses by $7.12M

Business Insider52 · neutralearnings

3d ago

Bioventus Inc. (BVS) files 8-K

SEC 8-K50 · neutralgeneral

3d ago

Bioventus Reports Third Quarter Financial Results

GlobeNewswire58 · neutralearnings

3d ago

Bioventus to Report Third Quarter of Fiscal Year 2026 Financial Results on November 2, 2026

Business Insider50 · neutralgeneral

Oct 27

Bioventus: Cash Flow Anchors The Bull Case Beyond A Potential Sale

Seeking Alpha65 · bullishanalyst

Sep 21

Bioventus Earnings Call Highlights Growth Amid Review

TipRanks56 · neutralearnings

Aug 21

Bioventus (BVS) Q2 2026 Earnings Call Transcript

The Motley Fool56 · neutralearnings

Aug 13

Bioventus price target raised to $18 from $16 at Craig-Hallum

The Fly61 · neutralanalyst

Aug 6

Bioventus Inc. 2026 Q2 - Results - Earnings Call Presentation

Seeking Alpha50 · neutralearnings

Aug 5

Bioventus Inc. (BVS) Q2 2026 Earnings Call Transcript

Seeking Alpha50 · neutralearnings

Aug 5

Bioventus Earnings Shine with Record GAAP EPS and Strategic Alternatives Review: Pain Treatments Up 12.8% in the U.S. August 5, 2026

MarketChameleon73 · bullishearnings

Aug 5

Bioventus Q2 Earnings Call Highlights

Yahoo Finance56 · neutralearnings

Aug 5

Bioventus Reports Solid Q2 Results Amid Strategic Review

TipRanks68 · bullishearnings

Aug 5

Bioventus Inc. (BVS) files 8-K

SEC 8-K50 · neutralgeneral

Aug 5

Open BVS in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →